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Methods and results: Characteristics, treatments and 30-day mortality were
recorded for 1408/1901 consecutive ACS patients. Changes in global model fit,
discrimination, calibration and reclassification were evaluated upon addition of
CRP to the GRACE risk score. High-CRP patients (CRP >22 mg/L, 4th quartile of
CRP) were older, had more comorbidities and worse hemodynamic conditions,
received less recommended treatment and had a four-fold higher 30 day mortality.
Multivariable analysis demonstrated high-CRP as an important and independent
predictor of mortality. Addition of high-CRP in the GRACE model improved
global fit, discriminatory capacity and calibration. Patients were divided into 4
groups according to GRACE risk score prediction: <1%, 1 to <5%, 5 to <10% and
>=10%. The model with high-CRP allowed adequate reclassification in 12.2%.
Conclusions: Elevated CRP level is an independent and important predic-
tive factor of 30-day mortality in ACS patients, even after adjustment for co-
morbidities, hemodynamic conditions and treatment. Combined with the
GRACE risk score, CRP information improves risk classification.
047
Coronary angioplasty of the chronic total occlusion. Outcome and
study of the Balance Risc and Benefit. A study of 62 cases
Kais Battikh, Maher Souissi, M Lotfi Slimane
CHU Habib Thameur Tunis, Cardiologie, Tunis, Tunisie
Percutaneous coronary intervention (PCI) of the coronary chronic total
occlusion (CTO) is widely discussed because of the difficulty and the risks of
the procedure and the controversial but very interesting clinical benefit in case
of procedure success.
Objective: To evaluate the in-hospital and long-term clinical outcome of
PCI in the case of CTO and measure the adverse effects and complications.
Methods: 62 cases of PCI for a CTO were consecutively registered from
January 2005 to February 2009. In addition to an assessment of the technical
characteristics and procedural outcomes, patients were followed for occurrence
of major adverse cardiac events (MACE). These patients are distributed in two
groups: (A) for the occlusion between 1 and 3 months age and (B) for the occlu-
sion of more than 3 months age. RESULTS: 68 lesions were treated in these 62
patients (47 male and 15 female) with mean age of 59 years (40-80). 42% of
theses patients were diabetics, 48% smoker and 26% with hypertension. 27
patients had an ST elevation acute coronary syndrome (ACS) and 24 a non ST
elevation ACS, where 2 had stable angina. Balloon angioplasty was performed
in only 4 cases and the stenting in 58 cases with use of 64 stents (average of 1.1
stent / artery and of 1.2 stent / patient), we used drug eluting stent in only 10
case (15.6 %). Total procedure success rate, defined by a patent artery (less then
30% residual stenosis) with TIMI 3 flow (grade 3) at the end of the PCI was 83
%( 57/68) . The success was better in the group A 90% (29/32) then the group
B 77% (28/36) (P < 0.05). The most frequent cause of procedure failures was
unsuccessful crossing with the wire in 6 cases and no severe acute complications
were done. Theses CTO required long procedures with an average time of fluo-
roscopy of 30 ’ 13 ", an average calculated dose radiation DAP of 20611 cGy /
cm2 and a high mean amount of contrast media 289.46 ml. At the preliminary
clinical results, patients with successful PCI of a CTO had a significantly better
clinical outcome than those whose PCI was unsuccessful.
048
Does heart rate predict coronary allograft vasculopathy and coronary
events in heart transplant recipients?
Pierre Ambrosi (1), Gilbert Habib (1), Bernard Kreitmann (2)
(1) Hôpital de la Timone, Service de Cardiologie, Marseille, France – (2)
Hôpital de la Timone, Chirurgie cardiaque, Marseille, France
Previous studies have shown that heart rate is a predictor of coronary
events and cardiovascular mortality. Moreover, pathophysiological studies
indicate that a relatively high heart rate has detrimental effects on the progres-
sion of coronary atherosclerosis. Heart transplant recipients frequently have
sinus tachycardia related to cardiac denervation. Therefore we evaluated the
prognostic importance of heart rate in heart transplant recipients.
143 consecutive heart transplant recipients (age at transplantation: 48.5±13
years) with at least a 2 year survival after transplantation were studied with a
9.5 year mean follow-up (range 2-23 years). Basal heart rate was measured at
rest 3 months after heart transplantation in the absence of beta-blocker therapy
or acute rejection. Survival without cardiac event was compared between
patients with basal heart rate < or >95/min (median) according to Kaplan-
Meier method using log-rank test.
Fifty-six patients had coronary irregularities or stenoses at routine biennal
coronary angiography and 87 had angiographically normal coronary arteries
during the follow-up. Mean basal heart rate did not significantly differ between
these two groups (96.4/min vs 98.3/min p=0.34). Twenty-seven patients had a
coronary event (myocardial infarction, percutaneous coronary intervention or
coronary death). Survival without coronary event did not significantly differ
between patients with basal heart rate > or < 95/min (logrank p= 0,97).
Conclusion: This series does not support a prognostic influence of heart
rate for cardiac allograft vasculopathy or coronary events in heart transplant
recipients.
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Background: Operators and patient radiation exposure during interven-
tional cardiology procedures may induce radiation injury and may increase
risk of cancer.
Objectives: To determine the effectiveness of a lead cover placed over the
patient abdomen and groins in reducing operator radiation exposure during
coronary intervention.
Methods: Radiation exposure measurements were performed over an 8
weeks period, in patients undergoing diagnostic and/or interventional coronary
procedures. Usual protection of the operator was ensured using a lead apron, low
leaded flaps, and leaded glass. Each of three procedures was realized using a
lead cover placed on the patient abdomen. Operator irradiation was assessed by
using 3 electronic dosimeters placed over the apron on the chest and in the back
(no 1, 2) on the left arm (no 3). Patient radiation exposure (using the diamentor
system), ambiental irradiation (using an electronic dosimeter placed in the room
opposite to the Xray tube) and fluoroscopy times were recorded. Results are pre-
sented in mean ± SEM and comparisons assessed by student t test.
Results: Operator exposure was assessed during 189 procedures (136 coronary
angiograms and 53 percutaneous coronary interventions) in 71 cases (37%) with
the lead cover over the patient (group 1) and in 118 cases (63%) without it (group
2). Fluoroscopy times, dose area products and ambient irradiation were similar
with and without the lead cover (4 ± 2 vs 4.1 ± 0.6 min, 55,7 ± 5,8 vs 57,6 ± 4,2
Gy cm2 and 0.7 ± 0.2 vs 0.8 ± 0.1 μSv respectively – p > 0.05). However, operator
irradiation was markedly decreased by using the lead cover: from 19.2 ± 3.1 to 4.9
± 0.9 μSv at the chest level (p=0,001), from 1.8 ± 0.3 to 0.3 ± 0.1 μSv at the back
(p=0.002) and from 25.8 ± 4.7 to 10.2 ± 2.2 μSv at the left arm (p=0,019).
Conclusions: Using a lead cover placed over the patient is highly effective
in attenuating operator scatter radiation exposure during coronary procedure.
Such additional protection device might be useful either in the perspective of
long duration procedure or in routine use.
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Background: Percutaneous coronary intervention (PCI) is the cornerstone of
revascularization in acute coronary syndromes (ACS). The radial artery cathete-
